Earnings Call · Q1 FY2022·2022-05-12

Q1 22EPS -20.00%·Rev n/aQ4 21EPS 0.00%·Rev n/aQ3 21EPS 0.00%·Rev n/aQ2 21EPS +42.86%·Rev n/a⚠ consensus missing

Matinas BioPharma Holdings, Inc. MTNB

Peter Vozzo — Chief Financial Officer

Jerome Jabbour — Chief Executive Officer

Theresa Matkovits — Chief Medical Officer

Terry Ferguson — Vice President of Research

Keith Kucinski — Chief Accounting Officer

+2.0%1d on move date+2.1% vs SPY3d+5.1%5d+3.5%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more MTNB calls or request research access.

More MTNB calls Browse calls Request research access